Study of PM060184 in Patients With Advanced Solid Tumors

Status:
Completed

Trial end date:
2015-08-01

Target enrollment:

Participant gender:

The purpose of the study is to determine the maximum tolerated dose and the recommended dose and to evaluate the safety and tolerability of PM060184.

Phase 1

PharmaMar